Biora Therapeutics, Inc. Debt Conversion, Converted Instrument, Amount
Biora Therapeutics, Inc. reported Debt Conversion, Converted Instrument, Amount of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2024-11-14
- Biora Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2023-12-31 was $1.00M.
- Biora Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Biora Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Biora Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2021-12-31 was $40.89M.
- Biora Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2023 was $51.00M.
- Biora Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Biora Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2021 was $44.61M, a 137.90% increase from fiscal 2020.
- Biora Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2020 was $18.75M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |||
| 2023-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $51.00M 10-K · filed 2024-04-01 | ||
| 2023-09-30 | $50.00M 10-Q · filed 2024-11-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 10-K · filed 2024-04-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | |||
| 2021-12-31 | $40.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $42.54M derived: sum of 2 quarters · filed 2023-03-30 | $44.61M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.71M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $2.07M 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | $18.75M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $18.75M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $18.75M 10-Q · filed 2021-08-12 |